Kim Monkhorst
Papers
1
Total Citations
86
H-Index
1
About
Dr. Kim Monkhorst is a leading figure in the field of precision oncology, with a primary focus on the clinical implementation of comprehensive genomic profiling for cancer diagnostics. Her most impactful work centers on the validation and application of whole genome sequencing (WGS) as a transformative tool for cancer care. In her landmark 2021 study, which has garnered 86 citations, Monkhorst demonstrated the clinical viability of using WGS on fresh-frozen tumor tissue and matched blood samples, positioning it as a potential "all-in-one" genetic test. This work directly addresses the critical challenge of maximizing diagnostic yield from increasingly small biopsy samples, while simultaneously screening for a growing number of actionable biomarkers. By advocating for a single, comprehensive test over a patchwork of targeted assays, Monkhorst’s research is paving the way for more efficient, cost-effective, and complete molecular diagnostics. Her contributions are instrumental in moving the field from targeted panels toward a future where whole genome analysis becomes the standard of care, ultimately enabling more personalized treatment strategies for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics86 citations · 2021